Startupbootcamp Digital Health Miami 18
Dec 11 '17-Mar 20 '18 (14 weeks)
About Startupbootcamp Digital Hea...
Applications for our 2017 program are now closed. The much anticipated Selection Day event will be held on November 18th. Follow us on Facebook to watch the event live! bit.ly/2hRV6E3
Startupbootcamp’s first U.S. program was made possible through a $2 Million grant from the Knight Foundation. We support and scale extraordinary companies transforming healthcare and eradicating disparities. To date, we have invested in ten companies from across the US, Latin America and Israel.
Miami is a center for healthcare innovation: it counts sixteen hospitals, over 1,000 life science companies, three globally recognized research universities and a legacy of successful healthcare companies.
If you are building a transformative company we invite you to join us. We provide funding, implementation and contract opportunities, a mentor network of industry leaders and and top tier investors, workspace and a comprehensive suite of services so that you can focus on what you do best: building a game-changing businesses. Our promise is simple: your startup will achieve one year of progress in three months.
During the program, selected startups will accelerate their companies and position themselves for scale with the help of:
- Implementations with leading hospital systems including UHealth, Jackson Health System, Nicklaus Children’s Hospital and many others
- Access to a national network of healthcare providers, insurers, technology companies and universities including Ascension, Carolinas Health Care System, Dell Medical Center, Mount Sinai, Aetna, Florida Blue, Microsoft, CVS Health, Philips, Abbvie, MIT and Harvard among many others
- 200+ angels & VCs like Bessemer Venture Partners, Flare Capital, Maverick Capital Ventures, Zaffre Investments and many more top-tier healthcare investors.
The program is led by Christian Seale and Joseph Whitner leveraging their experience being on both sides of the table as entrepreneur and early stage investors.
We're not connecting right now - follow us to keep updated